Opioid peptides, opioid receptors and mechanism of down regulation

Indian Journal of Experimental Biology

Volumn 41, Issue 1, 2003, Pages 5-13

  Chaturvedi, Kirti ^a,b  

^a Rutgers University   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; NEUROLOGY;

ANATOMICAL DISTRIBUTIONS;

BIOCHEMISTRY;

OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL; CHEMISTRY; DOWN REGULATION; GENETICS; MOLECULAR CLONING; PHYSIOLOGY; PROTEIN CONFORMATION; REVIEW;

ANIMALS; CLONING, MOLECULAR; DOWN-REGULATION; OPIOID PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, OPIOID;

ANIMALIA;

EID: 0037220621     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Wood P W, Iyengar S & Pasternak G W, Central actions of opiates and opioid peptides, in The Opiate Receptors, edited by Pasternak G W (Humana Press, Clifton, NJ) 1988, 307.
2. Hughes J, Smith T W, Kosterlitz H W, Fothergill L A, Morgan B A & Morris H R, Identification of two related pentapeptides from the brain with potent opiate agonist activity, Nature, 258 (1975) 577.
3. Li C H & Chung D, Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands, Proc Natl Acad Sci USA, 73 (1976) 1145.
4. Pasternak G W, Simantov R & Snyder S H, Characterization of endogenous morphine-like factor (enkephalin) in mammalian brain, Mol Pharmacol, 12 (1976) 504.
5. Goldstein A, Tachibana S, Lowney L I, Hunkapiller M & Hood L, Dynorphin-(1-13), an extraordinarily potent opioid peptide, Proc Natl Acad Sci USA, 76 (1979) 6666.
6. Noda M, Furutani Y, Takahashi H, Toyosato M, Hirose T, Inayama S, Nakanishi S & Numa S, Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin, Nature, 295 (1982) 202.
7. Kakidani H, Furutani Y, Takahashi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S & Numa S, Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor, Nature, 298 (1982) 245.
8. Nakanishi S, Inoue A, Kita T, Nakamura M, Chang A C, Cohen S N & Numa S, Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor, Nature, 278 (1979) 423.
9. Zadina J E, Hackler L, Ge L J, Kastin A J, A potent and selective endogenous agonist for the mu-opiate receptor, Nature, 386 (1997) 499.
10. Reinscheid R K, Nothacker H P, Bourson A, Ardati A, Henningsen R A, Bunzow J R, Grandy D K, Langen H, Monsma F J Jr & Civelli O, Orphanin FQ: A neuropeptide that activates an opioid-like G protein-coupled receptor, Science, 270 (1995) 792.
11. Przewlocki R & Przewlocka B, Opioids in chronic pain, Eur J Pharmacol, 429 (2001) 79.
12. Viveros O H, Diliberto E J Jr, Hazum E & Chang K J, Opiate-like materials in the adrenal medulla: Evidence for storage and secretion with catecholamines, Mol Pharmacol, 16 (1979) 1101.
13. Watson S J, Akil H, Ghazarossian V E & Goldstein A, Dynorphin immunocytochemical localization in brain and peripheral nervous system: Preliminary studies, Proc Natl Acad Sci USA, 78 (1981) 1260.
14. Lima D, Avelino A & Coimbra A, Morphological characterization of marginal (lamina I) neurons immunoreactive for substance P, enkephalin, dynorphin and gamma-aminobutyric acid in the rat spinal cord, J Chem Neuroanat, 6 (1993) 43.
15. Hassan A H, Pzewlocki R, Herz A N & Stein C, Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflammed tissue of the rat, Neurosci Lett, 140 (1992) 85.
16. Mansour A, Khachaturian H, Lewis M E, Akil H & Watson S J, Anatomy of CNS opioid receptors, Trends Neurosci, 11 (1988) 308.
17. Bugnon C, Bloch B, Lenys D, Gouget A & Fellmann D, Comparative study of the neuronal populations containing beta-endorphin, corticotropin and dopamine in the arcuate nucleus of the rat hypothalamus, Neurosci Lett, 14 (1979) 43.
18. Bronstein D M, Schafer M K, Watson S J & Akil H, Evidence that beta-endorphin is synthesized in cells in the nucleus tractus solitarius: Detection of POMC mRNA, Brain Res, 587 (1992) 269.
19. Maley B E, Immunohistochemical localization of neuropeptides and neurotransmitters in the nucleus solitarius, Chem Senses, 21 (1996) 367.
20. Martin-Schild S, Gerall A A, Kastin A J & Zadina J E, Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers, Peptides, 19 (1998) 1783.
21. Pierce T L, Grahek M D & Wessendorf M W, Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey, Neuroreport, 9 (1998) 385.
22. Zadina J E, Martin-Schild S, Gerall A A, Kastin A J, Hackler L, Ge L J & Zhang X, Endomorphins: Novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density, Ann N Y Acad Sci, 897 (1999) 136.
23. Schulz S, Schreff M, Nuss D, Gramsch C & Hollt V, Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions, Neuroreport, 7 (1996) 3021.
24. Simon E J, Hiller J M & Edelman I, Stereospecific binding of the potent narcotic analgesic (3H) etorphine to rat-brain homogenate, Proc Natl Acad Sci USA, 70 (1973) 1947.
25. Terenius L, Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex, Acta Pharmacol Toxicol (Copenh), 32 (1973) 317.
26. Pert C B, Pasternak G & Snyder S H, Opiate agonists and antagonists discriminated by receptor binding in brain, Science, 182 (1973) 1359.
27. Lord J A, Waterfield A A, Hughes J & Kosterlitz H W, Endogenous opioid peptides: Multiple agonists and receptors, Nature, 267 (1977) 495.
28. Kosterlitz H W, Paterson S J & Robson L E, Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain, Br J Pharmacol, 73 (1981) 939.
29. Evans C J, Keith D E Jr, Morrison H, Magendzo K & Edwards R H, Cloning of a delta opioid receptor by functional expression, Science, 258 (1992) 1952.
30. Kieffer B L, Befort K, Gaveriaux-Ruff C & Hirth C G, The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization, Proc Natl Acad Sci USA, 89 (1992) 12048.
31. Yasuda K, Raynor K, Kong H, Breder C D, Takeda J, Reisine T & Bell G I, Cloning and functional comparison of kappa- and delta-opioid receptors from mouse brain, Proc Natl Acad Sci USA, 90 (1993) 6736.
32. Chen Y, Mestek A, Liu J & Yu L, Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors, Biochem J, 295 (1993) 625.
33. Chen Y, Mestek A, Liu J, Hurley J A & Yu L, Molecular cloning and functional expression of a mu-opioid receptor from rat brain, Mol Pharmacol, 44 (1993) 8.
34. Fukuda K, Kato S, Mori K, Nishi M & Takeshima H, Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes, FEBS Lett, 327 (1993) 311.
35. Thompson R C, Mansour A, Akil H & Watson S J, Cloning and pharmacological characterization of a rat mu opioid receptor, Neuron, 11 (1993) 903.
36. Meng F, Xie G X, Thompson R C, Mansour A, Goldstein A, Watson S J & Akil H, Cloning and pharmacological characterization of a rat kappa opioid receptor, Proc Natl Acad Sci USA, 90 (1993) 9954.
37. Wang J B, Imai Y, Eppler C M, Gregor P, Spivak C E & Uhl G R, mu opiate receptor: cDNA cloning and expression, Proc Natl Acad Sci USA, 90 (1993) 10230.
38. Wang J B, Johnson P S, Imai Y, Persico A M, Ozenberger B A, Eppler C M & Uhl G R, cDNA cloning of an orphan opiate receptor gene family member and its splice variant, FEBS Lett, 348 (1994) 75.
39. Abood M E, Noel M A, Farnsworth J S & Tao Q, Molecular cloning and expression of a delta-opioid receptor from rat brain, J Neurosci Res, 37 (1994) 714.
40. Libert F, Parmentier M, Lefort A, Dinsart C, Van Sande J, Maenhaut C, Simons M J, Dumont J E & Vassart G, Selective amplification and cloning of four new members of the G protein-coupled receptor family, Science, 244 (1989) 569.
41. Meunier J C, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour J L, Guillemot J C, Ferrara P & Monsarrat B, Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor, Nature, 377(1995) 532.
42. Reinscheid R K, Higelin J, Henningsen R A, Monsma F J Jr & Civelli O, Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities, J Biol Chem, 273 (1998) 1490.
43. Singh V K, Bajpai K, Biswas S, Haq W, Khan M Y & Mathur K B, Molecular biology of opioid receptors: Recent advances, Neuroimmunomodulation, 4 (1997) 285.
44. Meunier J, Mouledous L & Topham C M, The nociceptin (ORL1) receptor: Molecular cloning and functional architecture, Peptides, 21 (2000) 893.
45. Tallent M, Dichter M A, Bell G I & Reisine T, The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells, Neuroscience, 63 (1994) 1033.
46. 2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells, Mol Pharmacol, 47 (1995) 1041.
47. 2+ channels in GH3 cells by cloned mu- and delta-opioid receptors, Mol Pharmacol, 50 (1996) 947.
48. Johnson P S, Wang J B, Wang W F & Uhl G R, Expressed mu opiate receptor couples to adenylate cyclase and phosphatidyl inositol turnover. Neuroreport, 5 (1994) 507.
49. 2+ from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes, Biochem Pharmacol, 54 (1997) 809.
50. Henry D J, Grandy D K, Lester H A, Davidson N & Chavkin C, Kappa-opioid receptors couple to inwardly rectifying potassium channels when coexpressed by Xenopus oocytes, Mol Pharmacol, 47 (1995) 551.
51. Li L Y & Chang K J, The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors, Mol Pharmacol, 50 (1996) 599.
52. Clapham D E & Neer E J, New roles for G-protein beta gamma-dimers in transmembrane signaling, Nature, 365 (1993) 403.
53. Surratt C K, Johnson P S, Moriwaki A, Seidleck B K, Blaschak C J, Wang J B, Uhl G R, mu-opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity, J Biol Chem, 269 (1994) 20548.
54. Befort K, Tabbara L, Bausch S, Chavkin C, Evans C & Kieffer B, The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site, Mol Pharmacol, 49 (1996) 216.
55. Mansour A, Taylor L P, Fine J L, Thompson R C, Hoversten M T, Mosberg H I, Watson S J & Akil H, Key residues defining the mu-opioid receptor binding pocket: A site-directed mutagenesis study, J Neurochem, 68 (1997) 344.
56. Claude P A, Wotta D R, Zhang X H, Prather P L, McGinn T M, Erickson L J, Loh H H & Law P Y, Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists, Proc Natl Acad Sci USA, 93 (1996) 5715.
57. Chaturvedi K, Shahrestanifar M & Howells R D, mu Opioid receptor: Role for the amino terminus as a determinant of ligand binding affinity. Brain Res Mol Brain Res, 76 (2000) 64.
58. Chaturvedi K, Christoffers K H, Singh K & Howells R D, Structure and regulation of opioid receptors, Biopolymers, 55 (2000) 334.
59. George S R, Zastawny R L, Briones-Urbina R, Cheng R, Nguyen T, Heiber M, Kouvelas A, Chan A S & O'Dowd B F, Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain, Biochem Biophys Res Commun, 205 (1994) 1438.
60. Mansour A, Fox C A, Burke S, Meng F, Thompson R C, Akil H & Watson S J, Mu, delta and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study, J Comp Neurol, 350 (1994) 412.
61. Mansour A, Fox C A, Thompson R C, Akil H & Watson S J, mu-Opioid receptor mRNA expression in the rat CNS: Comparison to mu-receptor binding, Brain Res, 643 (1994) 245.
62. Delfs J M, Kong H, Mestek A, Chen Y, Yu L, Reisine T & Chesselet M F, Expression of mu opioid receptor mRNA in rat brain: An in situ hybridization study at the single cell level, J Comp Neurol, 345 (1994) 46.
63. Arvidsson U, Riedl M, Chakrabarti S, Vulchanova L, Lee J H, Nakano A H, Lin X, Loh H H, Law P Y & Wessendorf M W, The kappa-opioid receptor is primarily postsynaptic: Combined immunohistochemical localization of the receptor and endogenous opioids, Proc Natl Acad Sci USA, 92 (1995) 5062.
64. Simonin F, Gaveriaux-Ruff C, Befort K, Matthes H, Lannes B, Micheletti G, Mattei M G, Charron G, Bloch B & Kieffer B, Kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system, Proc Natl Acad Sci USA, 92 (1995) 7006.
65. Monteillet-Agius G, Fein J, Anton B & Evans C J, ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing, J Comp Neurol. 399 (1998) 373.
66. Mansour A, Fox C A, Akil H & Watson S J, Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications, Trends Neurosci, 18 (1995) 22.
67. Chaturvedi K, Bandari P, Chinen N & Howells R D, Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors, J Biol Chem, 276 (2001) 12345.
68. Lefkowitz R J,G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization, J Biol Chem, 273 (1998) 18677.
69. Ferguson S S, Downey W E 3rd, Colapietro A M, Barak L S, Menard L & Caron M G, Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization, Science, 271 (1996) 363.
70. Goodman O B Jr, Krupnick J G, Santini F, Gurevich V V, Penn R B, Gagnon A W, Keen J H & Benovic J L, Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor, Nature, 383 (1996) 447.
71. Miller W E, Maudsley S, Ahn S, Khan K D, Luttrell L M & Lefkowitz R J, Beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of Beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis, J Biol Chem, 275 (2000) 11312.
72. Kornilova E, Sorkina T, Beguinot L & Sorkin A, Lysosomal targeting of epidermal growth factor receptors via a kinase-dependent pathway is mediated by the receptor carboxyl-terminal residues, J Biol Chem, 271 (1996) 30340.
73. Pei G, Kieffer B L, Lefkowitz R J & Freedman N J, Agonist-dependent phosphorylation of the mouse delta-opioid receptor: Involvement of G protein-coupled receptor kinases but not protein kinase C, Mol Pharmacol, 48 (1995) 173.
74. Zhang J, Ferguson S S, Barak L S, Bodduluri S R, Laporte S A, Law P Y & Caron M G, Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness, Proc Natl Acad Sci U S A, 95 (1998) 7157.
75. Chu P, Murray S, Lissin D & von Zastrow M, Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist, J Biol Chem, 272 (1997) 27124.
76. Tsao P I & von Zastrow M, Type-specific sorting of G protein-coupled receptors after endocytosis, J Biol Chem, 275 (2000) 11130.
77. Whistler J L, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P, Murray S R & von Zastrow M, Modulation of postendocytic sorting of G protein-coupled receptors, Science, 297 (2002) 615.
78. Mori S, Tanaka K, Omura S & Saito Y, Degradation process of ligand-stimulated platelet-derived growth factor beta-receptor involves ubiquitin-proteasome proteolytic pathway, J Biol Chem, 279 (1995) 29447.
79. Obin M S, Jahngen-Hodge J, Nowell T & Taylor A, Ubiquitinylation and ubiquitin-dependent proteolysis in vertebrate photoreceptors (rod outer segments). Evidence for ubiquitinylation of Gt and rhodopsin, J Biol Chem, 271 (1996) 14473.
80. Keith D E, Murray S R, Zaki P A, Chu P C, Lissin D V, Kang L, Evans C J & von Zastrow M. Morphine activates opioid receptors without causing their rapid internalization, J Biol Chem, 271 (1996) 19021.
81. Keith D E, Anton B, Murray S R, Zaki P A, Chu P C, Lissin D V, Monteillet-Agius G, Stewart P L, Evans C J & von Zastrow M, mu-Opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain, Mol Pharmacol, 53 (1998) 377.
82. Cvejic S & Devi L A, Dimerization of the delta opioid receptor: Implication for a role in receptor internalization, J Biol Chem, 272 (1997) 26959.
83. Trapaidze N, Keith D E, Cvejic S, Evans C J & Devi L A, Sequestration of the delta opioid receptor. Role of the C terminus in agonist-mediated internalization, J Biol Chem, 271 (1996) 29279.
84. Jockers R, Angers S, Da Silva A, Benaroch P, Strosberg A D, Bouvier M & Marullo S, Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis, J Biol Chem, 274 (1999) 28900.
85. Li J G, Luo L Y, Krupnick J G, Benovic J L & Liu-Chen L Y, U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation, J Biol Chem, 274 (1999) 12087.
86. Li JG, Benovic J L & Liu-Chen L Y, Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: Internalization is required for down-regulation. Mol Pharmacol. 58 (2000) 795.
87. Spampinato S, Di Toro R & Qasem A R, Nociceptin-induced internalization of the ORL1 receptor in human neuroblastoma cells, Neuroreport, 12 (2001) 3159.
88. Sehba F, Duttaroy A, Shah S, Chen B, Carroll J & Yoburn B C, In vivo homologous regulation of mu-opioid receptor gene expression in the mouse, Eur J Pharmacol, 339 (1997) 33.
89. Tao P L, Chang L R, Law P Y, Loh H H, Decrease in delta-opioid receptor density in rat brain after chronic [D-Ala2,D-Leu5]enkephalin treatment, Brain Res, 462 (1988) 313.
90. Yoburn B C, Nunes F A, Adler B, Pasternak G W & Inturrisi C E, Pharmacodynamic supersensitivity and opioid receptor upregulation in the mouse, J Pharmacol Exp Ther, 239 (1986) 132.
91. Puttfarcken P S & Cox B M, Morphine-induced desensitization and down-regulation at mu-receptors in 7315C pituitary tumor cells, Life Sci, 45 (1989) 1937.
92. Loh H H, Tao P L & Smith A P, Role of receptor regulation in opioid tolerance mechanisms, Synapse, 2 (1988) 457.
93. Law P Y & Loh H H, Regulation of opioid receptor activities. J Pharmacol Exp Ther, 289 (1999) 607.
94. Duttaroy A & Yoburn B C, The effect of intrinsic efficacy on opioid tolerance, Anesthesiology, 82 (1995) 1226.
95. Aceto M D, Bowman E R, May E L, Harris L S, Woods J H, Smith C B, Medzihradsky F & Jacobson A E, Very long-acting narcotic antagonists: The 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives, Arzneimittelforschung, 39 (1989) 570.
96. Comer S D, Burke T F, Lewis J W & Woods J H, Clocinnamox: A novel, systemically-active, irreversible opioid antagonist, J Pharmacol Exp Ther, 262 (1992) 1051.
97. Burke T F, Woods J H, Lewis J W & Medzihradsky F, Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice, J Pharmacol Exp Ther, 271 (1994) 715.
98. Zemig G, Butelman E R, Lewis J W, Walker E A & Woods J H, In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox, J Pharmacol Exp Ther, 269 (1994) 57.
99. Baran A, Shuster L, Eleftheriou B E, Bailey D W, Opiate receptors in mice: Genetic differences, Life Sci, 17 (1975) 633.
100. Moskowitz A S & Goodman R R, Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice, Brain Res, 360 (1985) 108.
101. Duttaroy A, Shen J, Shah S, Chen B, Sehba F, Carroll J & Yoburn B C, Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice, Life Sci, 65 (1999) 113.
102. Yoburn B C, Shah S, Chan K, Duttaroy A & Davis T, Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: Relationship to receptor selectivity, Pharmacol Biochem Behav, 51 (1995) 535.
103. Stafford K, Gomes A B, Shen J & Yoburn B C, mu-Opioid receptor downregulation contributes to opioid tolerance in vivo, Pharmacol Biochem Behav, 69 (2001) 233.